The Food and Drug Administration has not evaluated these statements. This product is not designed to diagnose, treat, cure, or prevent any medical condition. Not intended for human consumption.
Glucagon-Like Peptide-1 (GLP-1) is an incretin-related peptide analog examined for its involvement in glucose-regulation pathways, insulin-signaling dynamics, and neuroendocrine feedback mechanisms. In vitro, GLP-1 and its analogs are used to study receptor-specific activity, degradation kinetics, and metabolic responses in pancreatic and neuronal cell models.
Image 1 of 1